ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	15/116	191/7206	3.39990770374e-07
ko04657	IL-17 signaling pathway	10/116	87/7206	1.11752058894e-06
ko05131	Shigellosis	9/116	82/7206	5.82122466888e-06
ko04621	NOD-like receptor signaling pathway	12/116	157/7206	7.31585037354e-06
ko04217	Necroptosis	12/116	178/7206	2.61768199815e-05
ko04380	Osteoclast differentiation	10/116	134/7206	5.40512404338e-05
ko05164	Influenza A	11/116	167/7206	7.14365008438e-05
ko04668	TNF signaling pathway	9/116	120/7206	0.000124657890249
ko04064	NF-kappa B signaling pathway	8/116	96/7206	0.00014432333392
ko05160	Hepatitis C	10/116	153/7206	0.000164613912129
ko04215	Apoptosis - multiple species	5/116	47/7206	0.000886711853612
ko05167	Kaposi's sarcoma-associated herpesvirus infection	10/116	191/7206	0.000964239436836
ko05132	Salmonella infection	7/116	98/7206	0.000965954246493
ko05146	Amoebiasis	7/116	99/7206	0.0010258295674
ko05134	Legionellosis	6/116	74/7206	0.00116193914452
ko04933	AGE-RAGE signaling pathway in diabetic complications	8/116	135/7206	0.00143373937747
ko04210	Apoptosis	9/116	180/7206	0.00238047253944
ko05133	Pertussis	6/116	87/7206	0.00267496133634
ko05120	Epithelial cell signaling in Helicobacter pylori infection	6/116	92/7206	0.00354004351725
ko05145	Toxoplasmosis	7/116	126/7206	0.00407799962154
ko05142	Chagas disease (American trypanosomiasis)	7/116	130/7206	0.00484128414566
ko05100	Bacterial invasion of epithelial cells	6/116	99/7206	0.00508074081575
ko04620	Toll-like receptor signaling pathway	6/116	100/7206	0.00533555893629
ko05014	Amyotrophic lateral sclerosis (ALS)	5/116	74/7206	0.00660455629929
ko01524	Platinum drug resistance	5/116	76/7206	0.00738524025427
ko05152	Tuberculosis	8/116	187/7206	0.0103541582577
ko05205	Proteoglycans in cancer	10/116	271/7206	0.0117103732945
ko04144	Endocytosis	12/116	342/7206	0.0120803997036
ko04662	B cell receptor signaling pathway	5/116	88/7206	0.0134580235725
ko04912	GnRH signaling pathway	6/116	122/7206	0.013621823998
ko04750	Inflammatory mediator regulation of TRP channels	6/116	122/7206	0.013621823998
ko04666	Fc gamma R-mediated phagocytosis	6/116	122/7206	0.013621823998
ko04622	RIG-I-like receptor signaling pathway	4/116	62/7206	0.0173737341136
ko05418	Fluid shear stress and atherosclerosis	7/116	173/7206	0.0212638433985
ko04932	Non-alcoholic fatty liver disease (NAFLD)	7/116	182/7206	0.0271458168332
ko01521	EGFR tyrosine kinase inhibitor resistance	5/116	106/7206	0.0277697410093
ko04960	Aldosterone-regulated sodium reabsorption	3/116	41/7206	0.0278087807788
ko04623	Cytosolic DNA-sensing pathway	3/116	41/7206	0.0278087807788
ko04012	ErbB signaling pathway	5/116	109/7206	0.0308346987367
ko04115	p53 signaling pathway	4/116	74/7206	0.0309748465058
ko04130	SNARE interactions in vesicular transport	3/116	44/7206	0.033378408528
ko05130	Pathogenic Escherichia coli infection	4/116	77/7206	0.0351317668806
ko05219	Bladder cancer	3/116	48/7206	0.0416368544782
ko04062	Chemokine signaling pathway	7/116	201/7206	0.0430089092825
ko04624	Toll and Imd signaling pathway	3/116	49/7206	0.0438478035634
ko04722	Neurotrophin signaling pathway	6/116	160/7206	0.0439260498022
ko04071	Sphingolipid signaling pathway	6/116	162/7206	0.0461917875403
ko04611	Platelet activation	6/116	163/7206	0.0473515773709
ko04660	T cell receptor signaling pathway	5/116	124/7206	0.0492934274283
ko01522	Endocrine resistance	5/116	124/7206	0.0492934274283